First persons receive injections of "made-in-Vietnam" COVID-19 vaccine
The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers, one man and two women aged 20-25, receiving injections at the Military Medical Academy.
The first person is vaccinated with Nanocovax, a made-in-Vietnam vaccine, at the Military Medical Academy on December 17. (Photo: VNA)
Hanoi (VNA) – The first human trial ofCOVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first threevolunteers, one man and two women aged 20-25, receiving injections at theMilitary Medical Academy.
Nanocovax, developed by the Nanogen PharmaceuticalBiotechnology JSC, is the first Vietnam-made COVID-19 vaccine to enter humantrials, with another two from other manufacturers to follow in February andMarch 2021.
The first candidates are among 60 volunteers, aged 18-50,selected for the first phase of the vaccine trials. They are divided into threegroups for receiving three doses of 25 mcg, 50 mcg and 75 mcg.
With safety staying first in vaccine clinical trials, thefirst volunteers received the minimum dose of 25 mcg. They will stay at separaterooms at the Military Medical Academy for the first 72 hours for medicalassessment. They will continue to be closely monitored at their residences forthe next 56 days.
A team of more than 40 medical experts has been set up todeal with unwanted side effects after the vaccination.
Prof. Dr. Do Quyet, Director of the Military Medical Academy, speaks to the press following the trial vaccination. (Photo: VNA)
“In the world, there have been very few vaccine trialswith unexpected reactions, and we hope Nanocovax vaccine is no exception,” saidProf. Dr. Do Quyet, Director of the Military Medical Academy.
“To ensure the highest safety for the volunteers, we hadto best prepare, even for the life-threatening circumstances,” he said.
“We pledge to assess [the vaccine] objectively, honestly,and transparently, and submit the proposals to the health ministry forlater-stage trials,” he continued./.
Cambodian Prime Minister Hun Sen said that the Ministers of Health and Finance have already signed a deal to obtain 20 percent of a vaccine through COVAX.
Vietnam now boasts a nationwide healthcare network with 1,665 hospitals, 384 of which are non-public, supported by local commune- and ward-level stations. At the end of 2024, hospital bed capacity reached 34 per 10,000 people, slightly above the global average.
The 56-year-old patient from Quang Tri province was discharged in stable condition as he no longer experienced shortness of breath and was able to walk, move around, and eat normally.
Associate Professor Dr. Nguyen Vu Trung, Director of the Pasteur Institute, said that under the MoU, the two sides committed to promoting diverse and practical collaborative activities, including joint conferences and workshops, exchanges of scholars, researchers and students, sharing academic materials, and the development of specific programmes and projects in scientific research, training, and epidemic prevention.
TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, and healthcare providers to develop a sustainable digital health ecosystem.
The partnership is under the framework of a Memorandum of Understanding on the development and implementation of the National Action Plan on Breast Cancer and Cervical Cancer Prevention and Control, signed in Hanoi on July 22.
An estimated 7 million Vietnamese are currently living with diabetes, but about 50% remain undiagnosed, a dangerous gap that is fuelling serious, preventable complications and increasing the burden on the healthcare system.
In 2024, Vietnam achieved 99% coverage for the first dose of the diphtheria, tetanus and pertussis vaccine, up from 80% in 2023. Immunisation coverage in the country has not only rebounded to the high levels seen before the COVID-19 pandemic but has now surpassed the rates recorded in 2019.
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in infections driven by the onset of the rainy season.
During the peak months of July and August 2025, the National Institute of Haematology and Blood Transfusion (NIHBT) needs at least 90,000 units of blood to supply 180 hospitals in the northern region. However, despite continuous efforts, the reserve blood is still short of 30,000 units.
The Hanoi ceremony highlighted efforts to ensure all citizens, especially women and youth, can access accurate information and healthcare services to make informed reproductive choices.
After such a long time, the law has revealed many limitations, prompting the Ministry of Health (MoH) to gather opinions to amend the law to give more chances to thousands of patients every year.
Currently, cardiovascular specialists from the 108 Military Central Hospital are working alongside a team of Prof.Dr. Jan D. Schmitto, Deputy Director of MHH’s Department of Cardiac, Thoracic, Transplantation and Vascular Surgery on clinical trials for MCS devices, implanted in heart failure patients either as a bridge to transplantation or as permanent treatment.
The centre not only serves residents living on the island, but also receives tens of thousands of visitors every year, according to Assoc Prof Dr Tang Chi Thuong, Director of the HCM CIty Department of Health.
Not only does Vietnam attract international tourists with its landscapes, culture, and cuisine, but it is also gradually becoming a reliable destination for medical treatment, offering high-quality services at reasonable costs.
Over the past six months, 150 communal health stations in provinces including Ha Giang, Bac Kan, Lang Son, Lao Cai, Lai Chau, Yen Bai, Tay Ninh, Hau Giang, Ben Tre and Ca Mau have been equipped with information technology systems. In addition, 117 key provincial healthcare workers have received training, with thousands more expected to follow.
During the COVID-19 pandemic in 2020, the Ministry of Health swiftly launched a telemedicine programme, connecting more than 1,000 medical establishments nationwide. The model, which remains in operation, has benefited tens of thousands of patients, including foreign nationals.
After more than three weeks of intensive treatment, the patient's pneumonia improved, breathing stabilised, sedation was reduced, and the breathing tube was removed. He is now conscious, able to eat orally, and in recovery.
The first person is vaccinated with Nanocovax, a made-in-Vietnam vaccine, at the Military Medical Academy on December 17. (Photo: VNA) 
Prof. Dr. Do Quyet, Director of the Military Medical Academy, speaks to the press following the trial vaccination. (Photo: VNA)
